PT1054671E - Nova utilizacao da ropivacaina para o controlo da dor - Google Patents

Nova utilizacao da ropivacaina para o controlo da dor

Info

Publication number
PT1054671E
PT1054671E PT99903972T PT99903972T PT1054671E PT 1054671 E PT1054671 E PT 1054671E PT 99903972 T PT99903972 T PT 99903972T PT 99903972 T PT99903972 T PT 99903972T PT 1054671 E PT1054671 E PT 1054671E
Authority
PT
Portugal
Prior art keywords
ropivacaine
new use
pain control
pain
control
Prior art date
Application number
PT99903972T
Other languages
English (en)
Inventor
Goran Isacsson
Dag Selander
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PT1054671E publication Critical patent/PT1054671E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
PT99903972T 1998-01-21 1999-01-11 Nova utilizacao da ropivacaina para o controlo da dor PT1054671E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9800139A SE9800139D0 (sv) 1998-01-21 1998-01-21 New use

Publications (1)

Publication Number Publication Date
PT1054671E true PT1054671E (pt) 2003-03-31

Family

ID=20409917

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99903972T PT1054671E (pt) 1998-01-21 1999-01-11 Nova utilizacao da ropivacaina para o controlo da dor

Country Status (11)

Country Link
US (2) US6395291B1 (pt)
EP (1) EP1054671B1 (pt)
JP (1) JP4456754B2 (pt)
AT (1) ATE228840T1 (pt)
AU (1) AU2444399A (pt)
DE (1) DE69904297T2 (pt)
DK (1) DK1054671T3 (pt)
ES (1) ES2189386T3 (pt)
PT (1) PT1054671E (pt)
SE (1) SE9800139D0 (pt)
WO (1) WO1999037301A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200611217A (en) * 2005-12-06 2006-04-01 Shin Hwa Biotech Co Ltd Human model for indexing nerve paths (locus) having corresponding relations and method for indexing
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US10111850B2 (en) * 2015-12-01 2018-10-30 Samuel Wilson Ester and cholinesterase inhibitor in long-acting nerve block
US20160030409A1 (en) * 2014-07-30 2016-02-04 Grigory Karmy Method for relieving chronic pain
US10751249B2 (en) * 2017-11-26 2020-08-25 Johnson Athletic Advantage LLC Trigger point dry needling in motion and method of use
BE1026845B1 (nl) 2018-12-07 2020-07-08 Fagron Compounding Services Nv Samenstelling voor gebruik in lokale infiltratie analgesie (LIA)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3379266D1 (en) 1983-08-01 1989-04-06 Astra Laekemedel Ab L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE451840B (sv) 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning
SE9401174D0 (sv) 1994-04-07 1994-04-07 Astra Ab New combination
DK0998288T4 (da) 1997-03-13 2005-08-22 James N Campbell Sammensætninger indeholdende kapasaicin eller kapsaicinanaloge og et lokalbedövelsesmiddel

Also Published As

Publication number Publication date
DE69904297T2 (de) 2003-08-21
US6395291B1 (en) 2002-05-28
AU2444399A (en) 1999-08-09
EP1054671B1 (en) 2002-12-04
ATE228840T1 (de) 2002-12-15
DK1054671T3 (da) 2003-02-24
EP1054671A1 (en) 2000-11-29
US20020156101A1 (en) 2002-10-24
ES2189386T3 (es) 2003-07-01
DE69904297D1 (de) 2003-01-16
US6620423B2 (en) 2003-09-16
WO1999037301A1 (en) 1999-07-29
JP4456754B2 (ja) 2010-04-28
SE9800139D0 (sv) 1998-01-21
JP2002501021A (ja) 2002-01-15

Similar Documents

Publication Publication Date Title
SE9701162D0 (sv) New use II
MXPA03002576A (es) Metodos para tratar lesiones musculares.
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
EE05419B1 (et) Asendatud oksasolidinoonid kombineeritud raviks
AR025964A1 (es) Tratamiento nasal topico
BR0214481A (pt) Método e composição para potenciação de um analgésico opiáceo
DE69931640D1 (de) Verwendung von acetylcholinesterasen hemmern zur herstellung eines arzneimittels zur behandlung von funktionellen und/oder organischen schmerzsyndromen
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
YU82602A (sh) Korišćenje il-18 inhibitora za lečenje i/ili prevenciju ateroskleroze
SE9701161D0 (sv) New use I
PT1054671E (pt) Nova utilizacao da ropivacaina para o controlo da dor
ATE256461T1 (de) Benutzung von comt-inhibitoren als analgetika
ATE322314T1 (de) Kosmetische hautbehandlungsmethode
MY136367A (en) Treatment of cognitive failure
PT1161239E (pt) 3-ciclopropilmetoxi-4-difluorometoxi-n-(3,5-dicloropirid-4-il)-benzamida para o tratamento da esclerose multipla
DE60128009D1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ES2165233T3 (es) Empleo de 1-fosfato de esfingosina, derivados de 1-fosfato de esfingosina y/o sus mezclas para el tratamiento de enfermedades cutaneas inflamatorias.
PT1133296E (pt) Nova aplicacao terapeutica da nicergolina
AU2002347984A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen
ZA9711468B (en) New use of comt inhibitors
ATE275949T1 (de) Verwendung von diminazen-di-aceturat und/oder pentamidin zur behandlung von malaria
PT980251E (pt) Factor de tecido para influenciar a formacao de vasos sanguineos
GR20010100390A (el) Χρηση του diclofenac h αποδεκτων αλατων αυτου για την αντιμετωπιση των εγκαυματων.
PT1282414E (pt) Compostos derivados de felbamato para o tratamento da dor neuropatica